Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Senate deal boosts markets By: MarketMinute.com Market Updates January 22, 2018 at 17:02 PM EST A Senate deal to end the government shutdown sent the markets soaring to a sharply higher close with the Dow surging 142 points to 26,214. Nasdaq leaped 71 points to 7408.On the upsideArray BioPharma (Nasdaq: ARRY) reported positive updated results from a Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, binimetinib and cetuximab.Analysts expect The Medicines Company's (Nasdaq: MDCO) inclisiran to outsell Esperion Therapeutics' (Nasdaq: ESPR) bemepedoic acid.Abercrombie & Fitch (NYSE: ANF) lifted its fourth quarter revenue outlook due to a strong holiday shopping season. On the downside Sanmina (Nasdaq: SANM) that first quarter results will fall short of previous guidance.PetMed Express (Nasdaq: PETS) reported higher third quarter earnings and revenue that topped analyst estimates but the stock price fell.II-Vl (Nasdaq: IIVI) introduced its tristimulus colorimeter filters but the stock price fell on concerns that production of the iPhone X will be scaled back.In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 4 to 3 on Nasdaq. The broader S&P 500 climbed 22 points to 2,832. Bitcoin collapsed $883 to $10,320. Related Stocks: Abercrombie & Fitch Company Array Technologies Inc Coherent Corp Esperion Theraptc Medicines Company NDX Petmed Express Inc Sanmina Corp Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Senate deal boosts markets By: MarketMinute.com Market Updates January 22, 2018 at 17:02 PM EST A Senate deal to end the government shutdown sent the markets soaring to a sharply higher close with the Dow surging 142 points to 26,214. Nasdaq leaped 71 points to 7408.On the upsideArray BioPharma (Nasdaq: ARRY) reported positive updated results from a Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, binimetinib and cetuximab.Analysts expect The Medicines Company's (Nasdaq: MDCO) inclisiran to outsell Esperion Therapeutics' (Nasdaq: ESPR) bemepedoic acid.Abercrombie & Fitch (NYSE: ANF) lifted its fourth quarter revenue outlook due to a strong holiday shopping season. On the downside Sanmina (Nasdaq: SANM) that first quarter results will fall short of previous guidance.PetMed Express (Nasdaq: PETS) reported higher third quarter earnings and revenue that topped analyst estimates but the stock price fell.II-Vl (Nasdaq: IIVI) introduced its tristimulus colorimeter filters but the stock price fell on concerns that production of the iPhone X will be scaled back.In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 4 to 3 on Nasdaq. The broader S&P 500 climbed 22 points to 2,832. Bitcoin collapsed $883 to $10,320. Related Stocks: Abercrombie & Fitch Company Array Technologies Inc Coherent Corp Esperion Theraptc Medicines Company NDX Petmed Express Inc Sanmina Corp